| Hepatitis B virus immunopathogenesis FV Chisari, C Ferrari Annual review of immunology 13 (1), 29-60, 1995 | 2402 | 1995 |
| Planning optimal grasps C Ferrari, J Canny Proceedings., 1992 IEEE International Conference on Robotics and Automation …, 1992 | 1225 | 1992 |
| Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection C Boni, P Fisicaro, C Valdatta, B Amadei, P Di Vincenzo, T Giuberti, ... Journal of virology 81 (8), 4215-4225, 2007 | 1173 | 2007 |
| The Role of Virus-Specific Cd8+ Cells in Liver Damage and Viral Control during Persistent Hepatitis B Virus Infection MK Maini, C Boni, CK Lee, JR Larrubia, S Reignat, GS Ogg, AS King, ... The Journal of experimental medicine 191 (8), 1269-1280, 2000 | 1168 | 2000 |
| Statements from the Taormina expert meeting on occult hepatitis B virus infection G Raimondo, JP Allain, MR Brunetto, MA Buendia, DS Chen, M Colombo, ... Journal of hepatology 49 (4), 652-657, 2008 | 1163 | 2008 |
| The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte response B Rehermann, C Ferrari, C Pasquinelli, FV Chisari Nature medicine 2 (10), 1104-1108, 1996 | 1108 | 1996 |
| A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea J Webster, G Piscitelli, A Polli, CI Ferrari, I Ismail, MF Scanlon New England Journal of Medicine 331 (14), 904-909, 1994 | 919 | 1994 |
| Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. G Missale, R Bertoni, V Lamonaca, A Valli, M Massari, C Mori, MG Rumi, ... The Journal of clinical investigation 98 (3), 706-714, 1996 | 848 | 1996 |
| PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion S Urbani, B Amadei, D Tola, M Massari, S Schivazappa, G Missale, ... Journal of virology 80 (22), 11398-11403, 2006 | 754 | 2006 |
| Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells A Bertoletti, A Sette, FV Chisari, A Penna, M Levrero, MD Carli, ... Nature 369 (6479), 407-410, 1994 | 719 | 1994 |
| Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. C Ferrari, A Penna, A Bertoletti, A Valli, AD Antoni, T Giuberti, A Cavalli, ... Journal of immunology (Baltimore, Md.: 1950) 145 (10), 3442-3449, 1990 | 675 | 1990 |
| Republished: Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection A Bertoletti, C Ferrari Postgraduate Medical Journal 89 (1051), 294-304, 2013 | 623 | 2013 |
| Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. C Boni, A Bertoletti, A Penna, A Cavalli, M Pilli, S Urbani, P Scognamiglio, ... The Journal of clinical investigation 102 (5), 968-975, 1998 | 600 | 1998 |
| T Cells with a CD4+CD25+ Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Chronic Hepatitis C Virus Infection T Boettler, HC Spangenberg, C Neumann-Haefelin, E Panther, S Urbani, ... Journal of virology 79 (12), 7860-7867, 2005 | 575 | 2005 |
| Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B P Fisicaro, C Valdatta, M Massari, E Loggi, E Biasini, L Sacchelli, ... Gastroenterology 138 (2), 682-693. e4, 2010 | 572 | 2010 |
| EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B: 13–14 September, 2002 Geneva, Switzerland Consensus statement (Long version) TE Jury Journal of Hepatology 39, 3-25, 2003 | 570 | 2003 |
| Direct ex vivo analysis of hepatitis B virus-specific CD8+ T cells associated with the control of infection MK Maini, C Boni, GS Ogg, AS King, S Reignat, CK Lee, JR Larrubia, ... Gastroenterology 117 (6), 1386-1396, 1999 | 510 | 1999 |
| A global scientific strategy to cure hepatitis B PA Revill, FV Chisari, JM Block, M Dandri, AJ Gehring, H Guo, J Hu, ... The lancet Gastroenterology & hepatology 4 (7), 545-558, 2019 | 492 | 2019 |
| Lamivudine treatment can overcome cytotoxic T‐cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy C Boni, A Penna, GS Ogg, A Bertoletti, M Pilli, C Cavallo, A Cavalli, ... Hepatology 33 (4), 963-971, 2001 | 486 | 2001 |
| Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis X Liu, P Invernizzi, Y Lu, R Kosoy, Y Lu, I Bianchi, M Podda, C Xu, G Xie, ... Nature genetics 42 (8), 658-660, 2010 | 483 | 2010 |
